Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER_GOV 1

Study Type

Observational 1

Sponsor

Cancer Type

Other 1Lymphoid 1

Conditions

Obesity 1Lymphoma, Follicular 1

Interventions

Radiotherapy, Intensity-Modulated 3Cisplatin 3pembrolizumab 2Metformin 2Laparoscopy 2Gemcitabine 2Capecitabine 2tremelimumab 1sintilimab 1nabiximols 1lenvatinib 1enzalutamide 1durvalumab 1capivasertib 1avelumab 1atezolizumab 1acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1abiraterone 1Zoledronic Acid 1Trastuzumab 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Rituximab 1Rehabilitation 1Radiotherapy, Conformal 1Radiosurgery 1Radiation Dose Hypofractionation 1Radiation 1Rabeprazole 1Proton Pump Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × OTHER_GOV × Fluorescence Polarization Immunoassay × Clear all
NCT06114498 2026-01-23

Hospital Register of Decompensated Heart Failure With Preserved Ejection Fraction

National Medical Research Center for Therapy and Preventive Medicine

Active not recruiting
240 enrolled
LymphoidOther

Lymphoma, Follicular, Obesity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡